Quantum-Si incorporated

NASDAQ:QSI

Biotechnology

Healthcare
$1.07 +5.02%

+$0.05 today

Market cap
$213.79M
Beta
3.17
P/E (TTM)
-2.1
EPS (TTM)
-$0.48
52W Low $0.69High $3.10

Volume 10.47M

Average 5.64M

QSI Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

Quantum-Si incorporatedNASDAQ: QSI

Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other current liabilities rises 698.3% from a year ago

Other current liabilities stood at $1.37M at the end of Q1 FY2026, up 698.3% from a year earlier and down 93.0% from the prior quarter.

Context

  • Other current liabilities amounted to 0.6% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
  • Other current liabilities increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether other current liabilities keeps rising in the next quarterly balance sheet after a +698.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.37M-93.0% QoQ
Last fiscal yearDec 2025
-$1.74M-438.3% YoY
Year agoMar 2025
$172K+698.3% since
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+698.3%——
1 year-438.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

USD · from the balance sheet

Latest · FY2025
(1.74M) USD
Year-over-year change
-438.3%

Other Current Liabilities vs competitors

How QSI compares with its peers on the latest reported figures

  • QSI's Mar 2026 other current liabilities of $1.37M is the 9th highest of the 11 companies compared; the peer median is $4.1M.
  • Its year-over-year change of +698.3% is the highest of 9, against a peer median of +73.6%.
  • Other current liabilities amounts to 0.6% of total assets for QSI, versus a peer median of 2.0%.
QSI Competitors Peer median
Other Current Liabilities for QSI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ADCTADC Therapeutics S.A.Mar 2026$57.7M +513.1%+142.1%19.8%
AUTLAutolus Therapeutics plcMar 2026$39.96M +71.0%+74.1%7.6%
SLDBSolid Biosciences Inc.Mar 2026$18.15M +122.3%+49.7%4.3%
ENGNenGene Holdings Inc.Apr 2026$17.41M +76.1%+132.3%5.7%
RCKTRocket Pharmaceuticals, Inc.Mar 2026$5.24M +26.8%+7.1%1.8%
AURAAura Biosciences, Inc.Mar 2026$2.97M -6.6%+27.3%2.2%
ANNXAnnexon, Inc.Mar 2026$2.71M +14.1%+254.6%1.0%
LBRXLB Pharmaceuticals Inc Common StockMar 2026$1.97M —+136.0%0.5%
QSIQuantum-Si incorporatedMar 2026$1.37M +698.3%—0.6%
DBVTDBV Technologies S.A.Mar 2026$500K +509.8%-71.9%0.2%
ALTAltimmune, Inc.Mar 2026$0 ——0.0%
Peer median (excluding QSI) $4.1M+73.6%+74.1%2.0%

Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents35.79M84.32M133.86M49.24M21.64M
Short-term Investments435.52M266.99M123.88M160.36M141.27M
Net Receivables00368K1.33M561K
Inventory003.95M4.07M3.2M
Other Current Assets5M6.87M4.26M3.01M9.19M
Total Current Assets477.17M358.18M266.31M218.01M175.86M
Property, Plant & Equipment (Net)15.88M32.61M30.71M29.05M16.66M
Goodwill9.48M0000
Intangible Assets00532K00
Long-term Investments000052.86M
Tax Assets00000
Other Non-current Assets690K697K695K808K234K
Total Non-current Assets26.05M33.3M31.94M29.86M69.75M
Total Assets503.23M391.49M298.25M247.87M245.61M
Account Payables3.39M3.9M1.77M1.93M1.62M
Short-term Debt00000
Tax Payables0001.34M0
Deferred Revenue00003.49M
Other Current Liabilities2.7M88K194K514K(1.74M)
Total Current Liabilities11.53M15.71M11.61M18.19M23.03M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.45M996K1.29M5.01M34K
Total Non-current Liabilities14.66M17.07M15.02M14.26M2.36M
Total Liabilities26.19M32.78M26.63M32.45M25.38M
Common Stock14K14K14K18K22K
Retained Earnings(267.23M)(399.67M)(495.63M)(596.64M)(697.98M)
Accumulated OCI00045K(6K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity477.03M358.71M271.62M215.42M220.23M
Total Debt8.08M17.45M15.3M12.95M4.17M
Net Debt(27.71M)(66.87M)(118.56M)(36.29M)(17.47M)

Quantum-Si incorporated

NASDAQ:QSI

Intrinsic Alpha fair value

Locked

Current Price

$1.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.